Long‐Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data
Early Intervention in Psychiatry · 2025
DOI: 10.1111/eip.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Early Intervention in Psychiatry, 2025. Verfasst von Taylor M Ward und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The primary objective was to analyse the prescribing and discontinuation rates of long‐acting injectable (LAI) antipsychotics among child and adolescent populations. The secondary objective was to assess if racial/ethnic differences existed between LAI antipsychotics and discontinuation rates.
Methods
Children and adolescents (2–17 years old) with schizophrenia or related disorders who received LAI antipsychotics between January 1, 2017 and December 31, 2021 were identified using Merative MarketScan Multi‐State Medicaid Database. Descriptive statistics summarised the rates of LAI antipsychotic use. Kaplan–Meier survival curves were examined, and Cox regression analyses conducted to compare the hazard of discontinuation across LAI antipsychotics ( p < 0.05).
Results
A total of 1277 out of 67 502 patients were included in the final analysis. The average age was 15.4 ± 1.7 years (range 7–17 years). Approximately 59% were male, with the most common races identified being Black (48%) and White (38%). Prescribing of LAI second‐generation antipsychotics occurred in about 94% of the population. The most common LAI antipsychotics prescribed included paliperidone palmitate 1 month (40%) and aripiprazole formulations (48%). When controlling for age group, gender and plan type, the discontinuation rate for paliperidone and aripiprazole formulations did not differ. However, LAI paliperidone palmitate was associated with a 46% lower hazard of discontinuation for White compared to Black populations (HR = 0.54; p = 0.01).
Conclusion
Despite the limited sample, this study explored the frequency of prescribing and discontinuation rates between LAI antipsychotics in children. Future studies may further explain the unique challenges (e.g., reasons for discontinuation) and economic impact LAI antipsychotics present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, University of Georgia, Athens, Georgia, USA.
- Department of Statistics, Franklin College of Arts and Sciences, University of Georgia, Athens, Georgia, USA.
- KnowFully Medical Education, Radnor, Pennsylvania, USA.
- Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Athens, Georgia, USA.
ORCID-Profile: Joshua Caballero
Zitieren
APA
Ward, T. M., Xu, J., Hall, D. B., Chen, X., Benavides, S., Young, H. N., & Caballero, J. (2025). Long‐Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.70063
Vancouver
Ward TM, Xu J, Hall DB, Chen X, Benavides S, Young HN, et al. Long‐Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data. Early Intervention in Psychiatry. 2025. doi:10.1111/eip.70063
BibTeX
@article{Ward2025,
author = {Ward, Taylor M and Xu, Jianing and Hall, Daniel B and Chen, Xianyan and Benavides, Sandra and Young, Henry N and Caballero, Joshua},
title = {Long‐Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data},
journal = {Early Intervention in Psychiatry},
year = {2025},
doi = {10.1111/eip.70063}
}
EUVIMED